In clinical practice, cerebral MRI in newborns is highly predictive of neurodevelopmental outcome after therapeutic hypothermia.


Journal

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
ISSN: 1532-2130
Titre abrégé: Eur J Paediatr Neurol
Pays: England
ID NLM: 9715169

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 07 10 2019
revised: 10 12 2019
accepted: 13 12 2019
pubmed: 29 12 2019
medline: 1 9 2020
entrez: 29 12 2019
Statut: ppublish

Résumé

In the trials, a substantial proportion of newborns who underwent therapeutic hypothermia (TH) had an adverse outcome after hypoxic-ischaemic encephalopathy (HIE). Cooled babies were noted to have fewer cerebral lesions on MRI but when present lesions were predictive of adverse outcome. We investigate the predictive value of cerebral MRI in babies who undergo cooling in the clinical setting outside of the clinical trials in a prospective UK cohort. Of 75 babies recruited from four centres, neurodevelopment was available for 69 (92%) with 29% (20/69) being abnormal. The unfavourable MRI group (n = 22) had significantly lower motor (p < 0.001), language (p < 0.001) and cognition (p < 0.001) scores on Bayley-III assessment, compared to the favourable MRI group (n = 47). On multiple regression there was a significant relationship between basal ganglia and thalami abnormality and motor (p = 0.002), cognition (p = 0.011) and language (p = 0.013) outcomes. Half of the babies who had an MRI predictive of adverse outcome (11/22) had highest grade cerebral palsy. Cerebral MRI had 95% sensitivity, 94% specificity, 91% PPV and 98% NPV in predicting neurodevelopment. In this clinical cohort, fewer children had adverse neurodevelopment after TH compared to the TH trials. However, half the children who had an MRI predictive of adverse ND outcome had the most severe form of cerebral palsy. In this cohort, cerebral MRI was found to be highly predictive of neurodevelopmental outcome.

Identifiants

pubmed: 31882277
pii: S1090-3798(19)30438-6
doi: 10.1016/j.ejpn.2019.12.018
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

127-133

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest All authors report no conflict of interests in the writing of this publication.

Auteurs

Pavithira Tharmapoopathy (P)

The Royal London Hospital, Barts Health NHS Trust, London, E1 1BB, UK; Centre for Neuroscience & Trauma, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, E1 2AT, UK.

Philippa Chisholm (P)

Homerton University Hospitals NHS Foundation Trust, London, E9 6SR, UK.

Akif Barlas (A)

The Royal London Hospital, Barts Health NHS Trust, London, E1 1BB, UK.

Marianna Varsami (M)

The Royal London Hospital, Barts Health NHS Trust, London, E1 1BB, UK.

Neelam Gupta (N)

University Hospital Southampton, Southampton, UK.

Georgia Ekitzidou (G)

Homerton University Hospitals NHS Foundation Trust, London, E9 6SR, UK.

Vennila Ponnusamy (V)

Ashford and St. Peter's Hospitals NHS Foundation Trust, Chertsey, UK; Centre for Genomics & Child Health, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, E1 2AT, UK.

Olga Kappelou (O)

Homerton University Hospitals NHS Foundation Trust, London, E9 6SR, UK.

Jane Evanson (J)

The Royal London Hospital, Barts Health NHS Trust, London, E1 1BB, UK.

Gabriel Rosser (G)

Centre for Genomics & Child Health, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, E1 2AT, UK.

Divyen K Shah (DK)

The Royal London Hospital, Barts Health NHS Trust, London, E1 1BB, UK; Centre for Neuroscience & Trauma, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, E1 2AT, UK. Electronic address: d.shah@qmul.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH